CHMP backs RASONQUE for metastatic pancreatic cancer
Positive opinion supports EU marketing authorisation
Read More
Author: John Pinching
Libtayo dosing backed by CHMP
Regimen update recommended across all indications
Read More
Sanofi breaks ground on new insulin facility
New Frankfurt site to boost long-term supply
Read More
RougeTx launches with $58 million series A financing for HHT therapy
New company to advance first‑in‑class treatment
Read More
Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease
Phase 2 development underway as DARE2 trial begins
Read More
